Last CNY15.33 CNY
Change Today +0.30 / 2.00%
Volume 12.0M
600267 On Other Exchanges
Symbol
Exchange
Shanghai
As of 3:05 AM 07/30/14 All times are local (Market data is delayed by at least 15 minutes).

zhejiang hisun pharmaceuti-a (600267) Snapshot

Open
CNY15.01
Previous Close
CNY15.03
Day High
CNY15.45
Day Low
CNY14.94
52 Week High
09/26/13 - CNY19.62
52 Week Low
05/19/14 - CNY13.53
Market Cap
12.9B
Average Volume 10 Days
6.5M
EPS TTM
CNY0.36
Shares Outstanding
839.7M
EX-Date
06/25/14
P/E TM
42.5x
Dividend
CNY0.11
Dividend Yield
0.72%
Current Stock Chart for ZHEJIANG HISUN PHARMACEUTI-A (600267)

Related News

No related news articles were found.

zhejiang hisun pharmaceuti-a (600267) Related Businessweek News

No Related Businessweek News Found

zhejiang hisun pharmaceuti-a (600267) Details

Zhejiang Hisun Pharmaceutical Co. Ltd. provides various pharmaceutical products and services to patients and its business partners. The company provides antineoplastic, cardiovascular, anti-infection, endocrine control, anti-parasite, anti-tumor, anti-infective, and anti-immunosuppressive drugs, as well as animal remedies and muscle and skeletal system products. It also provides APIs and finished drugs, and medical information and product consulting services. The company markets and distributes its products under the HISUN brand in approximately 70 regions and countries. It has collaboration with Ambrx Inc. to develop and commercialize bispecifics for cancer. The company was founded in 1956 and is headquartered in Taizhou, China.

Founded in 1956

zhejiang hisun pharmaceuti-a (600267) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

zhejiang hisun pharmaceuti-a (600267) Key Developments

Zhejiang Hisun Pharmaceutical Co., Ltd. Proposes Amendments to the Company's Articles of Association

Zhejiang Hisun Pharmaceutical Co., Ltd. proposed to approve the amendments to the Company's articles of association, at the company's 2nd extraordinary general meeting of 2014 to be held on July 29, 2014.

Zhejiang Hisun Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Jul 29, 2014

Zhejiang Hisun Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Jul 29, 2014., at 13:30 China Standard Time. Agenda: To approve bank loan guarantee for wholly-owned subsidiaries; to approve amendments to the Company's articles of association; and to approve amendments to the Company's rules of procedures governing shareholders' general meetings.

Zhejiang Hisun Pharmaceutical Co., Ltd. Approves Amendment to the Articles of Association

Zhejiang Hisun Pharmaceutical Co., Ltd. announced that at the board of director's meeting held on July 11, 2014, approved the proposal of amending some clauses in the articles of association.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600267:CH CNY15.33 CNY +0.30

600267 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600267.
View Industry Companies
 

Industry Analysis

600267

Industry Average

Valuation 600267 Industry Range
Price/Earnings 42.0x
Price/Sales 1.4x
Price/Book 2.6x
Price/Cash Flow 41.9x
TEV/Sales 0.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZHEJIANG HISUN PHARMACEUTI-A, please visit www.hisunpharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.